Navigation Links
Researchers developing device to predict proper light exposure for human health
Date:9/5/2007

>

The advent of electricity has dramatically changed our light and dark exposure patterns, and indoor lighting can be insufficient to stimulate the circadian clock, Rea said. Exposure to indoor light sources during the night, including computer screens, may be too bright or seen for too long, to properly set the timing of the circadian clock. These disruptions can desynchronize the circadian rhythm from the solar daytime/nighttime cycle, leading to sleep problems and psychosocial stress such as mood and eating disorders, depression, and possibly immune deficiencies.

Outdoor light levels during the day even under cloud cover or during the winter are of much higher levels than those found in windowless, electrically illuminated buildings, and this absence of suitable light may induce circadian darkness, Rea said. If an individuals circadian light intake is deficient during waking hours, our device will be able to reliably predict the light therapy necessary to resynchronize the circadian phase with the solar day.

Such treatments could range from standing outside for 15 minutes to sitting in front of a light box fitted with blue LEDs for a certain amount of time, says Rea.

Rea and his colleague Mariana Figueiro, assistant professor in the LRC and co-PI on the project, will collaborate with scientists from Brown and Yale universities on a study to uncover participants baseline circadian rhythms by collecting information regarding each persons sleeping and waking cycles, light intake, and fluctuations in sleep quality, stress markers, and gene expression, which are all controlled by the circadian rhythm. Then, using light therapy treatment, the team will attempt to shift each participants circadian phase.

The results of the study will provide scientists in the LRC with the information they need to determine the level of accuracy required for the new device to accurately predict light-induced shifting of the circadian phase, acco
'/>"/>

Contact: Amber Cleveland
clevea@rpi.edu
518-276-2146
Rensselaer Polytechnic Institute
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Researchers find how protein allows insects to detect and respond to pheromones
3. Researchers Uncover Key Step In Manufacture of Memory Protein
4. NYU researchers simulate molecular biological clock
5. Researchers reveal the infectious impact of salmon farms on wild salmon
6. Researchers identify target for cancer drugs
7. Vital step in cellular migration described by UCSD medical researchers
8. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
9. UCSD researchers maintain stem cells without contaminated animal feeder layers
10. Researchers discover molecule that causes secondary stroke
11. Researchers find missing genes of ancient organism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... 3, 2009) Van Andel Research Institute (VARI) ... (ABA) works at the molecular level to help plants respond ... findings, published in the journal Nature , could help ... and combat global food shortages. The findings could also ...
(Date:12/3/2009)... the past three years in the troposphere (lower atmosphere) ... results, which are the first of their kind in ... between 2002 and 2005. , Over recent years, physicists ... carbon dioxide (CO2) levels, and how these have evolved ...
(Date:12/2/2009)... cigarette smoke have an increased risk of developing lung cancer ... of this study are published in Cancer Epidemiology, Biomarkers ... Cancer Research, as part of a special tobacco focus in ... 219,000 Americans will be diagnosed with lung cancer; more than ...
Breaking Biology News(10 mins):VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3CO2 levels rising in troposphere over rural areas 2Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Procter 26 Gamble Pharmaceuticals Launches Asacol 28R 29 HD 28mesalamine 29 Delayed Release Tablets 4692 1Procter 26 Gamble Pharmaceuticals Launches Asacol 28R 29 HD 28mesalamine 29 Delayed Release Tablets 4692 2Procter 26 Gamble Pharmaceuticals Launches Asacol 28R 29 HD 28mesalamine 29 Delayed Release Tablets 4692 3Procter 26 Gamble Pharmaceuticals Launches Asacol 28R 29 HD 28mesalamine 29 Delayed Release Tablets 4692 4Procter 26 Gamble Pharmaceuticals Launches Asacol 28R 29 HD 28mesalamine 29 Delayed Release Tablets 4692 5Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet 4690 1Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet 4690 2Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet 4690 3Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet 4690 4Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet 4690 5Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet 4690 6Mixed Marks for Swine Flu Updates 50875 1Mixed Marks for Swine Flu Updates 50875 2
... DALLAS July 6, 2008 Tiny strands of genetic material ... as major players in gene regulation, the process inside cells that ... to fight disease. , The idea that RNA (ribonucleic acid) ... it has been unclear how RNA strands might regulate the process. ...
... Diversity among the ancestors of such marine creatures as ... rise beginning 144 million years ago with no clear ... This contradicts previous work showing dramatic increases beginning 248 ... diversity., "Some of the time periods in the past ...
... Mass., July 3, 2008 -- Sirtris, a GlaxoSmithKline company ... treat diseases of aging such as Type 2 Diabetes, ... today,s online edition of Cell Metabolism that ... showed an overall health improvement, including improved bone health, ...
Other Biology News:UT Southwestern researchers identify new targets for RNAs that regulate genes 2UT Southwestern researchers identify new targets for RNAs that regulate genes 3Ancient marine invertebrate diversity less explosive than thought 2Ancient marine invertebrate diversity less explosive than thought 3Long-term study of middle-aged mice shows 2Long-term study of middle-aged mice shows 3
(Date:12/2/2009)... /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") ... with its previously announced unit offering, the underwriters have ... additional 637,500 units. Each unit is comprised of one ... warrant, and was sold at a price of US$3.00 ...
(Date:12/2/2009)... LELYSTAD, The Netherlands, December 2 Pepscan Holding NV,the ... the generation of immune therapeutics today announced that it,has ... Officer. , Dr. Mol will ... overall management and strategic direction of the company. He ...
(Date:12/2/2009)... Gamida Cell announced today,a feasibility study evaluating ... gene therapy product which combines technology from Weill,Cornell ... have potential to,treat inherited anemias such as Cooley,s ... is developing a series of technologies to expand, ...
(Date:12/2/2009)... Emerald Dairy, Inc.,("Emerald Dairy" or the "Company") (OTC Bulletin ... children,s formula, milk powder and,soybean products in China, today ... issue of US Food & Drink Executive, a quarterly ... food and beverage industry. , ...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Dutch Biotech Company Pepscan Appoints New CEO 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2
... Support R&D Efforts and Clinical Trials Advancing,the BiTE ... Micromet, Inc.,(Nasdaq: MITI ) ("Micromet" or ... for the treatment of cancer,inflammation and autoimmune diseases, ... agreement with various institutional investors to raise,$40 million ...
... 19 - 22,2008, the fairgrounds in Dusseldorf, Germany ... - World Forum for Medicine. As the,leading international ... will,feature about 4,300 exhibitors, two major congresses, an ... at MEDICA 2008 will include the latest products ...
... BOSTON, Sept. 30 Solos Endoscopy, Inc. (Pink,Sheets: ... intends to expand,their current industry to include and ... by implementing a business,strategy. The Company,s strategy is ... its customer base., Solos Endoscopy expects continuous ...
Other Biology Technology:Micromet Announces Definitive Agreement for $40 Million Private Equity Placement 2Micromet Announces Definitive Agreement for $40 Million Private Equity Placement 3Micromet Announces Definitive Agreement for $40 Million Private Equity Placement 4MEDICA 2008 Returns in November 2Solos Endoscopy, Inc. Implements Strategy to Capitalize on $30 Billion Minimally Invasive Surgical Product Market 2
...
... autofluorescent pigment lipofuscin accumulates in the ... neurons. The presence of lipofuscin granules ... microscopy in the central nervous system ... emission spectra, which overlaps with those ...
Purified anti-LAT...
Polyclonal Antibody to AHI1 / Jouberin...
Biology Products: